Related Experiment Video
Updated: Apr 6, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
McArdle disease: 2 case reports
Carolina Diez Morrondo1, Lucía Pantoja Zarza1, Beatriz San Millán Tejado2
1Servicio de Reumatología, Hospital El Bierzo, Ponferrada, León, España.
Elevated creatine kinase (CK) can indicate myopathies. This study diagnosed McArdle disease, a metabolic disorder, in two patients with high CK levels and null myophosphorylase activity.
Area of Science:
- Neurology
- Metabolic Disorders
- Clinical Diagnostics
Background:
- Elevated serum creatine kinase (CK) levels frequently necessitate specialist referral.
- Myopathies represent a significant category of conditions causing increased CK.
- McArdle disease is identified as the most prevalent skeletal muscle carbohydrate metabolism disorder.
Observation:
- Two patients, a 72-year-old asymptomatic male and a 30-year-old female with mild symptoms, were evaluated for elevated CK.
- Both patients presented with normal electromyography results.
- Muscle biopsy revealed a complete absence of myophosphorylase activity in both individuals.
Findings:
- The diagnostic evaluation confirmed McArdle disease in both patients.
- Null myophosphorylase activity is a key indicator for McArdle disease diagnosis.
- The study highlights the utility of enzyme activity assays in muscle biopsies for diagnosing metabolic myopathies.
Implications:
- This case series underscores the importance of investigating elevated CK levels, even in asymptomatic individuals.
- Early diagnosis of McArdle disease allows for appropriate patient management and genetic counseling.
- Understanding the clinical spectrum of McArdle disease aids in differential diagnosis for unexplained myopathies.
More Related Videos
13:10In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers
Published on: August 1, 2014
10:55Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies